These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11247886)

  • 1. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P
    Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.
    Steinhart AH; Forbes A; Mills EC; Rodgers-Gray BS; Travis SP
    Aliment Pharmacol Ther; 2007 Jun; 25(12):1389-99. PubMed ID: 17539978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM; Brzezinski A; Lashner BA
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine as a maintenance treatment in Crohn's disease.
    Sutherland LR; Steinhart AH
    Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.
    Feagan BG
    Clin Gastroenterol Hepatol; 2004 May; 2(5):376-8. PubMed ID: 15118974
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

  • 8. Obstructing Crohn's disease of the duodenum: is surgery always mandatory?
    Karaoglu AO; Yukselen V
    Int J Clin Pract; 2004 Feb; 58(2):221-3. PubMed ID: 15055874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
    Ford AC; Khan KJ; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Mar; 106(3):413-20. PubMed ID: 20717106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case against using 5-aminosalicyclates in Crohn's disease: con.
    Stange EF
    Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP; Laegemidler F; Eskerod O
    Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mesalazine is effective in Crohn disease 1].
    Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
    Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
    Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
    Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
    [No Abstract]   [Full Text] [Related]  

  • 17. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M; Cammà C
    Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
    [No Abstract]   [Full Text] [Related]  

  • 18. Budesonide led to a greater remission rate and fewer severe adverse events than did mesalamine in Crohn's disease.
    Rutgeerts P
    Gut; 1999 Jul; 45(1):13-4. PubMed ID: 10498451
    [No Abstract]   [Full Text] [Related]  

  • 19. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Hayee BH; Harris AW
    Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improved treatment of Crohn's disease].
    Nau JY
    Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.